146 related articles for article (PubMed ID: 30938082)
21. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma.
Huang D; Zhang Y; Zhang W; Wang Y; Zhang P; Hong L; Zhou Y; Han T; Zhi T
Eur J Ophthalmol; 2013; 23(4):532-8. PubMed ID: 23483499
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single Institution experience.
Ali AA; Elsheikh SM; Elhaj A; Osman N; Abuidris D; Eltayeb EA; Mahgoub M; Hamdoun A; Babiker MM; Mohamedani AA; Elwali NE; Qaddoumi I
Ophthalmic Genet; 2011 Jun; 32(2):122-5. PubMed ID: 21366428
[TBL] [Abstract][Full Text] [Related]
23. [Signs of retinoblastoma].
Kobylarz J; Napora-Krawiec A; Anzel M; Kulec D; Michalik-Wójcik A; Romanowska-Dixon B
Przegl Lek; 2009; 66(11):937-9. PubMed ID: 20297633
[TBL] [Abstract][Full Text] [Related]
24. Clinical course of retinoblastoma.
Islam F; Zafar SN; Siddiqui SN; Khan A
J Coll Physicians Surg Pak; 2013 Aug; 23(8):566-9. PubMed ID: 23930873
[TBL] [Abstract][Full Text] [Related]
25. A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997-2007.
Wang YR; Jin RM; Xu JW; Zhang ZQ
Leuk Res; 2011 Dec; 35(12):1628-31. PubMed ID: 21802727
[TBL] [Abstract][Full Text] [Related]
26. [Retinoblastoma in Malawi: why are admissions too late?].
Schulze Schwering M; Gandiwa M; Msukwa G; Spitzer M; Kalua K; Molyneux EM
Ophthalmologe; 2014 Dec; 111(12):1189-93. PubMed ID: 25278348
[TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).
Luna-Fineman S; Barnoya M; Bonilla M; Fu L; Baez F; Rodríguez-Galindo C
Pediatr Blood Cancer; 2012 Apr; 58(4):545-50. PubMed ID: 21910211
[TBL] [Abstract][Full Text] [Related]
28. Impact of an education program on late diagnosis of retinoblastoma in Honduras.
Leander C; Fu LC; Peña A; Howard SC; Rodriguez-Galindo C; Wilimas JA; Ribeiro RC; Haik B
Pediatr Blood Cancer; 2007 Nov; 49(6):817-9. PubMed ID: 17009236
[TBL] [Abstract][Full Text] [Related]
29. Trilateral retinoblastoma: A systematic review of 211 cases.
Yamanaka R; Hayano A; Takashima Y
Neurosurg Rev; 2019 Mar; 42(1):39-48. PubMed ID: 28815312
[TBL] [Abstract][Full Text] [Related]
30. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.
Sitorus RS; Moll AC; Suhardjono S; Simangunsong LS; Riono P; Imhof S; Völker-Dieben HJ
Ophthalmic Genet; 2009 Mar; 30(1):31-6. PubMed ID: 19172508
[TBL] [Abstract][Full Text] [Related]
31. Treatment abandonment and refusal among children with central nervous system tumors in Jordan.
Amayiri N; Bouffet E
Pediatr Blood Cancer; 2021 Aug; 68(8):e29054. PubMed ID: 34022111
[TBL] [Abstract][Full Text] [Related]
32. Retinoblastoma in Karachi, Pakistan.
Bhurgri Y; Muzaffar S; Ahmed R; Ahmed N; Bhurgri H; Usman A; Faridi N; Malik J; Kazi LA; Bashir I; Kayani N; Bhurgri A; Pervez S; Hasan SH; Soomro AH
Asian Pac J Cancer Prev; 2004; 5(2):159-63. PubMed ID: 15244518
[TBL] [Abstract][Full Text] [Related]
33. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
34. Barriers to effective treatment of pediatric solid tumors in middle-income countries: can we make sense of the spectrum of nonbiologic factors that influence outcomes?
Friedrich P; Ortiz R; Fuentes S; Gamboa Y; Ah Chu-Sanchez MS; Arambú IC; Montero M; Báez F; Rodríguez-Galindo C; Antillón-Klussmann F;
Cancer; 2014 Jan; 120(1):112-25. PubMed ID: 24132910
[TBL] [Abstract][Full Text] [Related]
35. Retinoblastoma: one world, one vision.
Rodriguez-Galindo C; Wilson MW; Chantada G; Fu L; Qaddoumi I; Antoneli C; Leal-Leal C; Sharma T; Barnoya M; Epelman S; Pizzarello L; Kane JR; Barfield R; Merchant TE; Robison LL; Murphree AL; Chevez-Barrios P; Dyer MA; O'Brien J; Ribeiro RC; Hungerford J; Helveston EM; Haik BG; Wilimas J
Pediatrics; 2008 Sep; 122(3):e763-70. PubMed ID: 18762512
[TBL] [Abstract][Full Text] [Related]
36. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
[TBL] [Abstract][Full Text] [Related]
37. SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries.
Chantada G; Luna-Fineman S; Sitorus RS; Kruger M; Israels T; Leal-Leal C; Bakhshi S; Qaddoumi I; Abramson DH; Doz F;
Pediatr Blood Cancer; 2013 May; 60(5):719-27. PubMed ID: 23335388
[TBL] [Abstract][Full Text] [Related]
38. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
[TBL] [Abstract][Full Text] [Related]
39. The magnitude and predictors of therapy abandonment in pediatric central nervous system tumors in low- and middle-income countries: Systematic review and meta-analysis.
Seah T; Zhang C; Halbert J; Prabha S; Gupta S
Pediatr Blood Cancer; 2019 Jun; 66(6):e27692. PubMed ID: 30835958
[TBL] [Abstract][Full Text] [Related]
40. Delayed diagnosis of retinoblastoma.
Wirix M; Parys-Vanginderdeuren R; Casteels I; Uyttebrouck A
Bull Soc Belge Ophtalmol; 2000; (278):37-41. PubMed ID: 11761559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
